“Anosmia” the mysterious collateral damage of COVID-19 Abdulrahman K. AhmedReem SayadIbrahim M. Sayed Review 05 March 2022 Pages: 189 - 200
Herpes zoster preceding neuromyelitis optica spectrum disorder: casual or causal relationship? A systematic literature review Emanuela Claudia TurcoErica CurtiFranco Granella Mini-Review 24 April 2022 Pages: 201 - 207
Accelerated epigenetic aging in adolescents living with HIV is associated with altered development of brain structures Jacqueline HoareDan J. SteinAndrew J. Levine OriginalPaper 07 February 2021 Pages: 208 - 216
Interaction of declined handgrip strength and HIV infection on neurocognitive impairment Shiying YuanXiaoxiao ChenNa He OriginalPaper 06 December 2021 Pages: 217 - 224
Correction: Interaction of declined handgrip strength and HIV infection on neurocognitive impairment Shiying YuanXiaoxiao ChenNa He Correction 18 March 2022 Pages: 225 - 225
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders A. BarcoS. OrlandoA. Calcagno OriginalPaper 19 January 2022 Pages: 226 - 235
Neurological soft signs and brain morphology in people living with HIV Christina J. HeroldLi KongPablo Toro OriginalPaper Open access 29 March 2022 Pages: 236 - 247
Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder Rowan SalonerErin E. Morganthe TMARC Group OriginalPaper Open access 03 January 2022 Pages: 248 - 264
The impacts of HIV infection, age, and education on functional brain networks in adults with HIV Fan Nils YangShiva Hassanzadeh-BehbahaniXiong Jiang OriginalPaper 19 January 2022 Pages: 265 - 273
Cerebral vasculitis caused by Talaromyces marneffei and Aspergillus niger in a HIV-positive patient: a case report and literature review Yidong GaoMan QuMin Zhang OriginalPaper Open access 03 January 2022 Pages: 274 - 280
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid Dipesh SolankyJerel A. FieldsSanjay R. Mehta OriginalPaper 14 February 2022 Pages: 281 - 290
Main lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in HIV-1 subtypes C and B Sergio M. de AlmeidaMiriam Perlingeiro BeltrameRonald J. Ellis OriginalPaper 21 February 2022 Pages: 291 - 304
Human immunodeficiency virus-1 Tat exerts its neurotoxic effects by downregulating Sonic hedgehog signaling Irfan A. khanArthur H. WorradVir B. Singh Short Communication Open access 18 February 2022 Pages: 305 - 311
Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases Claudia Cristina Ferreira VasconcelosMariana Beiral HammerleKarina Lebeis Pires Short Communication 02 April 2022 Pages: 312 - 318
A case of ischemic stroke secondary to varicella-zoster virus meningoencephalitis Hangfei WuJiasi LiXiaoying Bi Case Report 11 March 2022 Pages: 319 - 321
SARS-CoV-2-associated haemorrhagic encephalitis mimicking Herpes encephalitis Rahul HandaSatyan NandaNalin Malhotra Case Report 08 April 2022 Pages: 322 - 325
Ependymal restricted diffusion and injury to the olfactory system on a ventriculoencephalitis associated with COVID-19 Americo Danúzio Pereira OliveiraAna Rosa Melo Corrêa LimaMaria de Fátima Viana Vasco Aragao Case Report 04 January 2022 Pages: 326 - 328
Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis Samantha EpsteinRiddhi ThakkarClaire S. Riley Case Report 03 January 2022 Pages: 329 - 334
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab Fabian BoeslKristina AllersChristiana Franke Case Report Open access 23 March 2022 Pages: 335 - 338
Neurological complications of COVID-19 in pediatric patients require comprehensive evaluation Josef Finsterer Letter to the Editor 11 March 2022 Pages: 339 - 340
